These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13818928)

  • 1. Tris(l-aziridinyl)phosphine oxide (TEPA).
    DUVALL LR
    Cancer Chemother Rep; 1960 Jul; 8():156-75. PubMed ID: 13818928
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial clinical study of tris(2,2-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132).
    Mittelman A; Plager J; Murphy GP
    Cancer Chemother Rep; 1972 Jun; 56(3):393-9. PubMed ID: 19051500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and antitumor activity of tris(2,3-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132).
    Munson AE; Babbitt HL; Chmielewicz ZF; Segaloff A; Bardos TJ; Ambrus JL
    Cancer Chemother Rep; 1967 Sep; 51(5):253-9. PubMed ID: 6075137
    [No Abstract]   [Full Text] [Related]  

  • 4. Thiono compounds. 4. In vitro mutagenic and antineoplastic activity of TEPA and thio-TEPA.
    Breau AP; Field L; Mitchell WM
    Cell Biol Toxicol; 1984 Oct; 1(1):21-30. PubMed ID: 6086064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CONTRIBUTION TO THE CHEMICAL AND PHARMACOLOGICAL STUDY OF AZIRIDINYL PHOSPHINE OXIDES].
    CHABRIER P; CHEYMOL G; NGUYENTHANH THUONG ; RIOULT P
    C R Seances Soc Biol Fil; 1964; 158():2057-9. PubMed ID: 14282110
    [No Abstract]   [Full Text] [Related]  

  • 6. [The queen technic for ant control. I. The effect of tepa on laboratory colonies of the pharaoh ant].
    Berndt KP; Nitschmann J
    Angew Parasitol; 1977 Feb; 18(1):1-18. PubMed ID: 67812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 2, 4, 6, Tri-amino-s-triazine (TR), 2, 4, 6 tris (ethyleneimino)-s-triazine (TEM) and N, N', N"-triethylenephosphoramide (TEPA) on rat litter in utero.
    THIERSCH JB
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):36-40. PubMed ID: 13400864
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacteriophage development in lysogenic Escherichia coli and mutations in fungi induced with analogs of tris(1-aziridinyl) phosphine oxide, TEPA.
    Zetterberg G
    Hereditas; 1971; 68(2):245-54. PubMed ID: 4142010
    [No Abstract]   [Full Text] [Related]  

  • 9. SYNTHESIS OF HEXAHYDROAZEPINYL-BIS(AZIRIDINYL)PHOSPHINE OXIDE, SULFIDE, AND RELATED COMPOUNDS FOR CANCER THERAPY.
    TSOU KC; HOEGERLE K
    J Med Chem; 1963 Jan; 6():47-9. PubMed ID: 14174030
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of antibiotics on the mutagenic activity induced by chemicals. I. Chromosome aberrations during spermatogenesis in mice.
    Srám RJ; Kocisová J
    Folia Biol (Praha); 1975; 21(1):60-4. PubMed ID: 47302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tris (1-aziridinyl)phosphine oxide: caution on use.
    Klassen W; Chang TH
    Science; 1966 Nov; 154(3751):920. PubMed ID: 6012326
    [No Abstract]   [Full Text] [Related]  

  • 12. In the search for new anticancer drugs XI. Anticancer activity of nitroxyl labeled phosphoric N,N;N',N';N",N"-tris[1,2-ethanediyl]triamide(TEPA) and phosphorothioic N,N;N',N';N",N"-tris[1,2-ethanediyl]triamide(thio-TEPA) derivatives.
    Sosnovsky G; Li SW
    Cancer Lett; 1985 Jan; 25(3):255-60. PubMed ID: 2578867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE STABILITY OF TEPA AND OTHER AZIRIDINE CHEMOSTERILANTS.
    BEROZA M; BORKOVEC AB
    J Med Chem; 1964 Jan; 7():44-9. PubMed ID: 14186023
    [No Abstract]   [Full Text] [Related]  

  • 14. Tris(1-aziridinyl)phosphine oxide.
    IARC Monogr Eval Carcinog Risk Chem Man; 1975; 9():75-84. PubMed ID: 62704
    [No Abstract]   [Full Text] [Related]  

  • 15. N-substituted ureidobis(1-aziridinyl)phosphine oxides.
    Rätz R; Gruber M
    J Med Chem; 1966 Jan; 9(1):144-6. PubMed ID: 5958941
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE ANTITUMOUR ACTION AND TOXICITY OF BIS-(1-AZIRIDINYL)-(BIS-(2-CHLOROETHYL)-AMINO)-PHOSPHINE OXIDE (AT-222) IN ANIMALS].
    CHOU CH; LIANG HC; HSU B
    Yao Xue Xue Bao; 1964 Sep; 11():617-25. PubMed ID: 14210246
    [No Abstract]   [Full Text] [Related]  

  • 17. The preparation of 2,6-disubstituted pyridinyl phosphine oxides as novel anti-cancer agents.
    Lam KH; Gambari R; Yuen MC; Kan CW; Chan P; Xu L; Tang W; Chui CH; Cheng GY; Wong RS; Lau FY; Tong CS; Chan AK; Lai PB; Kok SH; Cheng CH; Chan AS; Tang JC
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2266-9. PubMed ID: 19321340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary studies on the distribution and fate of TEM, TEPA, and myleran in the human.
    NADKARNI MV; TRAMS EG; SMITH PK
    Cancer Res; 1959 Aug; 19():713-8. PubMed ID: 14425726
    [No Abstract]   [Full Text] [Related]  

  • 19. Tertiary phosphines and phosphine oxides containing a 2-haloethyl group.
    Struck RF; Shealy YF
    J Med Chem; 1966 May; 9(3):414-6. PubMed ID: 5960918
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
    Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
    Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.